Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT02709226
What this trial is testing

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01870726
What this trial is testing

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Who this might be right for
c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Looking for participantsNCT04267978
What this trial is testing

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Who this might be right for
Glioblastoma, RecurrentLower Grade Glioma, Recurrent
Beijing Sanbo Brain Hospital 109
Not applicableStudy completedNCT04988750
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

Who this might be right for
Recurrent GlioblastomaHigh-Grade Glioma (WHO III-IV)Brain Tumor Recurrent+3 more
NaviFUS Corporation 7
Early research (Phase 1)Study completedNCT00045474
What this trial is testing

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00412542
What this trial is testing

Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas

Who this might be right for
Glioblastoma MultiformeGlioma
M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)Ended earlyNCT00515086
What this trial is testing

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Novartis Pharmaceuticals 41
Early research (Phase 1)Study completedNCT00734682
What this trial is testing

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+1 more
University of California, San Francisco 34
Testing effectiveness (Phase 2)UnknownNCT01252459
What this trial is testing

Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioma (Glioblastoma Multiforme)
University Hospital Freiburg 200
Testing effectiveness (Phase 2)Looking for participantsNCT04765098
What this trial is testing

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Who this might be right for
Glioblastoma Multiforme
AHS Cancer Control Alberta 60
Early research (Phase 1)Looking for participantsNCT07541781
What this trial is testing

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Who this might be right for
GliomaGlioblastomaRecurrent Glioma+2 more
Kailin Yang, MD, PhD 45
Testing effectiveness (Phase 2)Ended earlyNCT01113463
What this trial is testing

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT05084430
What this trial is testing

Study of Pembrolizumab and M032 (NSC 733972)

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaGliosarcoma
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Study completedNCT00016328
What this trial is testing

CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT04201873
What this trial is testing

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jonsson Comprehensive Cancer Center 46
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00397072
What this trial is testing

Epothilone in Recurrent Glioblastoma Patients

Who this might be right for
Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 15
Not applicableEnded earlyNCT01925573
What this trial is testing

Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)

Who this might be right for
RECURRENT GLIOBLASTOMABrain Tumor
University of Maryland, Baltimore 7
Early research (Phase 1)UnknownNCT04385173
What this trial is testing

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Next Page